Free Trial
ASX:ACL

Australian Clinical Labs (ACL) Stock Price, News & Analysis

Australian Clinical Labs logo

About Australian Clinical Labs Stock (ASX:ACL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$728.27 million
P/E Ratio
30.38
Dividend Yield
3.28%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ACL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Australian Clinical Labs and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ACL Stock News Headlines

Why Trump’s “Smart Dollar” could rewrite the rules
MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.tc pixel
See More Headlines

ACL Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Clinical Labs investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU), Coles Group (COL) and VelocityShares 1x Long VSTOXX Futures ETN (EVIX).

Company Calendar

Ex-Dividend for 9/22 Dividend
8/31/2025
Today
9/13/2025
Record date for 9/22 Dividend
9/22/2025
Dividend Payable
9/22/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
ASX:ACL
CIK
N/A
Fax
N/A
Employees
5,115
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A$0.12
Trailing P/E Ratio
30.38
Forward P/E Ratio
N/A
P/E Growth
-0.36
Net Income
A$23.93 million
Net Margins
3.45%
Pretax Margin
N/A
Return on Equity
13.98%
Return on Assets
6.67%

Debt

Debt-to-Equity Ratio
174.00
Current Ratio
0.64
Quick Ratio
0.53

Sales & Book Value

Annual Sales
A$696.37 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
A$0.89 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
201,830,000
Free Float
N/A
Market Cap
A$728.27 million
Optionable
Not Optionable
Beta
1.18
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (ASX:ACL) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners